{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:40:59Z","timestamp":1762324859410,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s40272-020-00425-z","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T02:02:19Z","timestamp":1605578539000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database"],"prefix":"10.1007","volume":"23","author":[{"given":"Adrien","family":"Gainville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Boyer","family":"Gervoise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Michot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Pizzoglio-Bellaudaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Chebane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Weckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3717-2784","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Durrieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"425_CR1","unstructured":"Surdit\u00e9 et d\u00e9ficience auditive [Internet]. 2020. Disponible sur: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/deafness-and-hearing-loss. Accessed 5 May 2020"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00003446-199810000-00001","volume":"19","author":"FH Bess","year":"1998","unstructured":"Bess FH, Dodd-Murphy J, Parker RA. Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status. Ear Hear. 1998;19:339\u201354.","journal-title":"Ear Hear."},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"KR Knight","year":"2005","unstructured":"Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23:8588\u201396.","journal-title":"J Clin Oncol."},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00106-019-0663-1","volume":"67","author":"G Laurell","year":"2019","unstructured":"Laurell G. Pharmacological intervention in the field of ototoxicity. HNO. 2019;67:434\u20139.","journal-title":"HNO."},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7874\/jao.2017.00360","volume":"22","author":"P Ganesan","year":"2018","unstructured":"Ganesan P, Schmiedge J, Manchaiah V, Swapna S, Dhandayutham S, Kothandaraman PP. Ototoxicity: a challenge in diagnosis and treatment. J Audiol Otol. 2018;22:59\u201368.","journal-title":"J Audiol Otol"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cpt.603","volume":"101","author":"C Lanvers-Kaminsky","year":"2017","unstructured":"Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, Ciarimboli G. Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies. Clin Pharmacol Ther. 2017;101:491\u2013500.","journal-title":"Clin Pharmacol Ther."},{"key":"425_CR7","first-page":"7946","volume":"24","author":"G Altissimi","year":"2020","unstructured":"Altissimi G, Colizza A, Cianfrone G, de Vincentiis M, Greco A, Taurone S, Musacchio A, Ciofalo A, Turchetta R, Angeletti D, Ralli M. Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide. Eur Rev Med Pharmacol Sci. 2020;24:7946\u201352.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0194599816640485","volume":"155","author":"L Roland","year":"2016","unstructured":"Roland L, Fischer C, Tran K, Rachakondra T, Kallogjeri D, Lieu J. Quality of life with hearing impairment: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016;155:208\u201319.","journal-title":"Otolaryngol Head Neck Surg."},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1136\/annrheumdis-2011-201265","volume":"71","author":"N Jourde-Chiche","year":"2012","unstructured":"Jourde-Chiche N, Mancini J, Dagher N, Taugourdeau S, Thomas G, Brunet C, Bornet C, Pastor MJ, Chiche L. Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French Pharmacovigilance Network. Ann Rheum Dis. 2012;71:1586.","journal-title":"Ann Rheum Dis."},{"key":"425_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01161","author":"MA Barbieri","year":"2019","unstructured":"Barbieri MA, Cicala G, Cutroneo PM, Mocciaro E, Sottosanti L, Freni F, Galletti F, Arcoraci V, Spina E. Ototoxic adverse drug reactions: a disproportionality analysis using the italian spontaneous reporting database. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.01161.","journal-title":"Front Pharmacol."},{"key":"425_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217951","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Hasegawa S, Nakao S, Shimada K, Mukai R, Matsumoto K, Nakamura M. Analysis of drug-induced hearing loss by using a spontaneous reporting system database. PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0217951.","journal-title":"PLoS ONE"},{"key":"425_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/fcp.12533","volume":"34","author":"S Favreli\u00e8re","year":"2020","unstructured":"Favreli\u00e8re S, Delaunay P, Lebreton JP, Rouby F, Atzenhoffer M, Lafay-Chebassier C, P\u00e9rault-Pochat MC. Drug-induced hearing loss: a case:non-case study in the French pharmacovigilance database. Fundam Clin Pharmacol. 2020;34:397\u2013407.","journal-title":"Fundam Clin Pharmacol."},{"key":"425_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.02.022","author":"K Bihan","year":"2020","unstructured":"Bihan K, Lebrun-Vignes B, Funck-Brentano C, Salem JE. Uses of pharmacovigilance databases: an overview. Therapie. 2020. https:\/\/doi.org\/10.1016\/j.therap.2020.02.022.","journal-title":"Therapie."},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","volume":"71","author":"G Miremont-Salam\u00e9","year":"2016","unstructured":"Miremont-Salam\u00e9 G, Th\u00e9ophile H, Haramburu F, B\u00e9gaud B. Causality assessment in pharmacovigilance: the French method and its successive updates. Therapie. 2016;71:179\u201386.","journal-title":"Therapie."},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.therap.2019.09.004","volume":"74","author":"N Moore","year":"2019","unstructured":"Moore N, Berda\u00ef D, Blin P, Droz C. Pharmacovigilance\u2014the next chapter. Therapie. 2019;74:557\u201367.","journal-title":"Therapie."},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255\u20139.","journal-title":"Lancet"},{"key":"425_CR17","unstructured":"Introductory Guide MedDRA Version 21.0. https:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_21._0_english.pdf. Accessed 15 May 2020."},{"key":"425_CR18","unstructured":"Guidelines for ATC classification and DDD assignment. World Health Organization; 2020. https:\/\/www.whocc.no\/atc_ddd_index_and_guidelines\/guidelines\/. Accessed 15 May 2020."},{"key":"425_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00308","author":"M Jiang","year":"2017","unstructured":"Jiang M, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: a review. Front Cell Neurosci. 2017. https:\/\/doi.org\/10.3389\/fncel.2017.00308.","journal-title":"Front Cell Neurosci."},{"key":"425_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40264-017-0629-8","volume":"41","author":"KCM Campbell","year":"2018","unstructured":"Campbell KCM, Le Prell CG. Drug-induced ototoxicity: diagnosis and monitoring. Drug Saf. 2018;41:451\u201364.","journal-title":"Drug Saf."},{"key":"425_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/17425255.2017.1234606","volume":"13","author":"A Smits","year":"2017","unstructured":"Smits A, Van den Arker J, Allegaert K. The amikacin research program: a stepwise approach to validate dosing regimens in neonates. Expert Opin Drug Metabol Toxicol. 2017;13:157\u201366.","journal-title":"Expert Opin Drug Metabol Toxicol."},{"key":"425_CR22","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1128\/AAC.00965-08","volume":"53","author":"Y Qian","year":"2009","unstructured":"Qian Y, Guan MX. Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation. Antimicrob Agents Chemother. 2009;53:4612\u20138.","journal-title":"Antimicrob Agents Chemother."},{"key":"425_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.joto.2017.02.001","volume":"12","author":"Z Gao","year":"2017","unstructured":"Gao Z, Chen Y, Guan MX. Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity. J Otol. 2017;12:1\u20138.","journal-title":"J Otol."},{"key":"425_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/AUD.0000000000000276","volume":"37","author":"II Maro","year":"2016","unstructured":"Maro II, Fellows AM, Clavier OH, Gui J, Rieke CC, Wilbur JC, Chambers RD, Jastrzembski BG, Mascari JE, Bakari M, Matee M, Musiek FE, Waddell RD, von Reyn CF, Palumbo PE, Moshi N, Buckey JC. Auditory impairment in HIV-infected children. Ear Hear. 2016;37:443\u201351.","journal-title":"Ear Hear."},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.4125","volume":"26","author":"EL Sagwa","year":"2017","unstructured":"Sagwa EL, Souverein PC, Ribeiro I, Leufkens HGM, Mantel-Teeuwisse AK. Differences in VigiBase\u00ae reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment. Pharmacoepidemiol Drug Saf. 2017;26:1\u20138.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"425_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00338","author":"S Sheth","year":"2017","unstructured":"Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci. 2017. https:\/\/doi.org\/10.3389\/fncel.2017.00338.","journal-title":"Front Cell Neurosci."},{"key":"425_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng.3217","volume":"47","author":"H Xu","year":"2015","unstructured":"Xu H, Robinson GW, Huang J, Lim JY, Zhang H, Bass JK, et al. Common variants in ACYP2 influence susceptibility to cisplatin induced hearing loss. Nat Genet. 2015;47:263\u20136.","journal-title":"Nat Genet."},{"key":"425_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/cam4.516","volume":"4","author":"AL Brown","year":"2015","unstructured":"Brown AL, Lupo PJ, Okcu MF, Lau CC, Rednam S, Scheurer ME. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med. 2015;4:1679\u201386.","journal-title":"Cancer Med."},{"key":"425_CR29","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/1097-0142(19810515)47:10<2404::AID-CNCR2820471014>3.0.CO;2-2","volume":"47","author":"SL Mahajan","year":"1981","unstructured":"Mahajan SL, Ikeda Y, Myers TJ, Baldini MG. Acute acoustic nerve palsy associated with vincristine therapy. Cancer. 1981;47:2404\u20136.","journal-title":"Cancer"},{"key":"425_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1017\/S0022215100093385","volume":"96","author":"A Serafy","year":"1982","unstructured":"Serafy A, Hashash M, State F. The effect of vinblastine sulphate on the neurological elements of the rabbit cochlea. J Laryngol Otol. 1982;96:975\u20139.","journal-title":"J Laryngol Otol."},{"key":"425_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1258\/0022215011908676","volume":"115","author":"C Uzun","year":"2001","unstructured":"Uzun C, Koten M, Adali MK, Yorulmaz F, Yagiz R, Karasalihoglu AR. Reversible ototoxic effect of azithromycin and clarithromycin on transiently evoked otoacoustic emissions in guinea pigs. J Laryngol Otol. 2001;115:622\u20138.","journal-title":"J Laryngol Otol."},{"key":"425_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/pgmj.2004.020412","volume":"81","author":"J Coulston","year":"2005","unstructured":"Coulston J, Balaratnam N. Irreversible sensorineural hearing loss due to clarithromycin. Postgrad Med J. 2005;81:58\u20139.","journal-title":"Postgrad Med J"},{"key":"425_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/0003489418788112","volume":"127","author":"CB Heffernan","year":"2018","unstructured":"Heffernan CB, McKeon MG, Molony S, Kawai K, Stiles DJ, Lachenauer CS, et al. Does clarithromycin cause hearing loss? A 12-year review of clarithromycin therapy for nontuberculous mycobacterial lymphadenitis in children. Ann Otol Rhinol Laryngol. 2018;127:687\u201393.","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"425_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/789143","author":"L Rosende","year":"2011","unstructured":"Rosende L, Verea-Hernando MM, de Andr\u00e9s A, Pi\u00f1eyro-Molina F, Barja J, Castro-Castro S, et al. Hypoacusia in a patient treated by isotretinoin. Case Rep Med. 2011. https:\/\/doi.org\/10.1155\/2011\/789143.","journal-title":"Case Rep Med."},{"key":"425_CR35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1365-4632.2011.04959.x","volume":"50","author":"H Karabulut","year":"2011","unstructured":"Karabulut H, Karadag AS, Acar B, Dagli M, Karabulut I, Ozmen E, et al. The effect of oral isotretinoin (13-cis retinoic acid) on hearing systems in patients with acne vulgaris: a prospective study. Int J Dermatol. 2011;50:1139\u201343.","journal-title":"Int J Dermatol."},{"key":"425_CR36","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.25011\/cim.v37i2.21092","volume":"37","author":"M Akdag","year":"2014","unstructured":"Akdag M, Akkurt ZM, Gul A, Ucmak D, Y\u0131lmaz B, Sengul E, et al. The effects of oral isotretinoin (13-Cis retinoic acid) on the inner ear: a prospective clinical study. Clin Invest Med. 2014;37:E102-107.","journal-title":"Clin Invest Med."},{"issue":"Supplementary","key":"425_CR37","first-page":"2579","volume":"31","author":"MA Alan","year":"2018","unstructured":"Alan MA, Ery\u0131lmaz MA, Kaymaz F, Suzer A, Ar\u0131c\u0131gil M. Isotretinoin\u2019s action against cisplatin-induced ototoxicity in rats. Pak J Pharm Sci. 2018;31(Supplementary):2579\u201384.","journal-title":"Pak J Pharm Sci."},{"key":"425_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/QCO.0000000000000263","volume":"29","author":"JM Lestner","year":"2016","unstructured":"Lestner JM, Hill LF, Heath PT, Sharland M. Vancomycin toxicity in neonates: a review of the evidence. Curr Opin Infect Dis. 2016;29:237\u201347.","journal-title":"Curr Opin Infect Dis."},{"key":"425_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224561","author":"C Humphrey","year":"2019","unstructured":"Humphrey C, Veve MP, Walker B, Shorman MA. Long-term vancomycin use had low risk of ototoxicity. PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0224561.","journal-title":"PLoS ONE"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-020-00425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-020-00425-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-020-00425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T03:07:56Z","timestamp":1611198476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-020-00425-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s40272-020-00425-z","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"type":"print","value":"1174-5878"},{"type":"electronic","value":"1179-2019"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"24 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors, AG, VR, FK, MBG, JM, VPB, LC, AW, JLM, and GD, declare that they have no conflicts of interest relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with international ethical guidelines. Ethics approval was not required for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"AG, VR, FK, LC, JLM, and GD all made substantial contributions to the concept and design, or analysis and interpretation of data, and to the drafting of the manuscript. All authors reviewed, contributed to revisions and approved the manuscript and accept full responsibility for its overall content.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}